These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19666482)

  • 1. Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process.
    Okwor I; Liu D; Beverley SM; Uzonna JE
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13951-6. PubMed ID: 19666482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
    Nagase H; Jones KM; Anderson CF; Noben-Trauth N
    J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated inoculation of killed Leishmania major induces durable immune response that protects mice against virulent challenge.
    Okwor I; Kuriakose S; Uzonna J
    Vaccine; 2010 Jul; 28(33):5451-7. PubMed ID: 20558242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis.
    Okwor I; Liu D; Uzonna J
    Vaccine; 2009 Apr; 27(19):2554-62. PubMed ID: 19428861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection.
    Tabbara KS; Peters NC; Afrin F; Mendez S; Bertholet S; Belkaid Y; Sacks DL
    Infect Immun; 2005 Aug; 73(8):4714-22. PubMed ID: 16040984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vector transmission of leishmania abrogates vaccine-induced protective immunity.
    Peters NC; Kimblin N; Secundino N; Kamhawi S; Lawyer P; Sacks DL
    PLoS Pathog; 2009 Jun; 5(6):e1000484. PubMed ID: 19543375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.
    Okwor I; Uzonna J
    Immunol Res; 2008; 41(2):123-36. PubMed ID: 18389179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.
    Lang T; Courret N; Colle JH; Milon G; Antoine JC
    Infect Immun; 2003 May; 71(5):2674-83. PubMed ID: 12704142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection.
    Gicheru MM; Olobo JO; Anjili CO; Orago AS; Modabber F; Scott P
    Infect Immun; 2001 Jan; 69(1):245-51. PubMed ID: 11119512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of Tregs does not preclude immunity to reinfection with Leishmania braziliensis.
    C Falcão S; de Moura TR; Clarêncio J; Brodskyn C; Barral A; de Oliveira CI
    Int J Parasitol; 2012 Jul; 42(8):771-80. PubMed ID: 22705204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
    Courret N; Lang T; Milon G; Antoine JC
    Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dectin-1 Positive Dendritic Cells Expand after Infection with
    Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
    Front Immunol; 2018; 9():263. PubMed ID: 29535708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.
    Belkaid Y; Von Stebut E; Mendez S; Lira R; Caler E; Bertholet S; Udey MC; Sacks D
    J Immunol; 2002 Apr; 168(8):3992-4000. PubMed ID: 11937556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
    Okwor I; Jia P; Uzonna JE
    J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection.
    Stober CB; Lange UG; Roberts MT; Alcami A; Blackwell JM
    J Immunol; 2005 Aug; 175(4):2517-24. PubMed ID: 16081824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in mice.
    Ehrchen JM; Roth J; Roebrock K; Varga G; Domschke W; Newberry R; Sorg C; Müller-Tidow C; Sunderkötter C; Kucharzik T; Spahn TW
    Infect Immun; 2008 Sep; 76(9):4241-50. PubMed ID: 18625738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.
    Anderson CF; Stumhofer JS; Hunter CA; Sacks D
    J Immunol; 2009 Oct; 183(7):4619-27. PubMed ID: 19748991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic dietary protein guides maturation of the host immune system promoting resistance to Leishmania major infection in C57BL/6 mice.
    Amaral JF; Gomes-Santos AC; Paula-Silva J; Nicoli JR; Vieira LQ; Faria AM; Menezes JS
    Immunology; 2010 Mar; 129(3):455-64. PubMed ID: 20002788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models.
    Solana JC; Ramírez L; Corvo L; de Oliveira CI; Barral-Netto M; Requena JM; Iborra S; Soto M
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005644. PubMed ID: 28558043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice.
    Iborra S; Parody N; Abánades DR; Bonay P; Prates D; Novais FO; Barral-Netto M; Alonso C; Soto M
    Microbes Infect; 2008; 10(10-11):1133-41. PubMed ID: 18603012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.